Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Subtype Heterogeneity and Epigenetic Convergence in Neuroendocrine Prostate Cancer [scRNA-seq]
PubMed Full text in PMC Similar studies
Subtype Heterogeneity and Epigenetic Convergence in Neuroendocrine Prostate Cancer [scATAC-seq]
Pyrvinium pamoate targets to multiple vulnerabilities of Merkel cell carcinoma
PubMed Full text in PMC Similar studies Analyze with GEO2R
Dynamics of host response to Merkel cell polyomavirus oncogenes
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Clinical subtyping of cancer from plasma based on comprehensive epigenomic profiling
Next-generation mRNA sequencing of MKL-1 Merkel cell carcinoma cells expressing wild-type or mutant YAP or TAZ
MKL-1 Merkel cell carcinoma cells treated with EPZ011989
Next-generation sequencing of CUT&RUN of MKL-1 Merkel cell carcinoma cells treated with EPZ011989
PubMed Full text in PMC Similar studies SRA Run Selector
Next-generation mRNA sequencing of MKL-1 Merkel cell carcinoma cells treated with EPZ011989
Subtype Heterogeneity and Epigenetic Convergence in Neuroendocrine Prostate Cancer
Subtype Heterogeneity and Epigenetic Convergence in Neuroendocrine Prostate Cancer [ATAC-seq]
Subtype Heterogeneity and Epigenetic Convergence in Neuroendocrine Prostate Cancer [ChIP-seq]
Subtype Heterogeneity and Epigenetic Convergence in Neuroendocrine Prostate Cancer [RNA-seq]
ADDICTION OF MERKEL CELL CARCINOMA TO MUC1-C IDENTIFIES A POTENTIAL NEW TARGET FOR TREATMENT OF THIS RECALCITRANT MALIGNANCY [MCC26]
ADDICTION OF MERKEL CELL CARCINOMA TO MUC1-C IDENTIFIES A POTENTIAL NEW TARGET FOR TREATMENT OF THIS RECALCITRANT MALIGNANCY [MKL1]
ADDICTION OF MERKEL CELL CARCINOMA TO MUC1-C IDENTIFIES A POTENTIAL NEW TARGET FOR TREATMENT OF THIS RECALCITRANT MALIGNANCY
RNA-seq profiling of A549 cells with sgRNA knockouts that confer prexasertib resistance
CHK1 Inhibitor Blocks Phosphorylation of FAM122A and Promotes Replication Stress
Analyze with GEO2RSRA Run Selector
Profiling chromatin accessible regions in Merkel cell carcinoma cells
LSD1-RCOR2 binding and LSD1 and BRD9 transcriptome analysis in Merkel cell carcinoma cells
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on